Molecular assay for detection of ciprofloxacin resistance in neisseria gonorrhoeae isolates from cultures and clinical nucleic acid amplification test specimens

Journal of Clinical Microbiology

Volumn 53, Issue 11, 2015, Pages 3606-3608

  Peterson, S W ^a   Martin, I ^a   Demczuk, W ^a   Bharat, A ^a   Hoang, L ^b   Wylie, J ^c   Allen, V ^d   Lefebvre, B ^e   Tyrrell, G ^f   Horsman, G ^g   Haldane, D ^h   Garceau, R ⁱ   Wong, T ^j   Mulveya, M R ^k  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c CADHAM PROVINCIAL LABORATORY   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^f PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^g Saskatchewan Disease Control Laboratory   (Canada)

^h QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

ⁱ Dumont Hospital   (Canada)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; GYRA GENE; LIMIT OF DETECTION; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PARC GENE; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; CANADA; CROSS REACTION; DRUG EFFECTS; GENETICS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES;

ANTI-BACTERIAL AGENTS; CANADA; CIPROFLOXACIN; CROSS REACTIONS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY;

EID: 84945196394     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01632-15     Document Type: Article

References (12)

1. Public Health Agency of Canada. 2014. Notifiable diseases on-line. Public Health Agency of Canada, Ottawa, Ontario, Canada. http://dsol-smed .phac-aspc.gc.ca/dsol-smed/ndis/charts.php?cpl.
2. Barry PM, Klausner JD. 2009. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 10:555-557. 10.1517/14656560902731993. http://dx.doi.org/10.1517/14656560902731993.
3. Public Health Agency of Canada, National Microbiology Laboratory. 2014. National surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae annual summary 2012. Public Health Agency of Canada, Ottawa, Ontario, Canada. http://publications.gc.ca/collections/collection-2 014/aspc-phac/HP57-3-2012-eng.pdf
4. Belland RJ, Morrison SG, Ison C, Huang WM. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions ofgyrA and parC in fluoroquinolone-resistant isolates. Mol Microbiol 14:371-380. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01297.x.
5. Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR. 2015. Molecular assay for the detection of genetic markers associated with decreased susceptibility to cephalosporins in Neisseria gonorrhoeae. J Clin Microbiol 53:2042-2048. http://dx.doi.org/10.1128/JCM.00493-15.
6. Martin I, Jayaraman G, Wong T, Liu G, Gilmour M, Canadian Public Health Laboratory Network. 2011. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009. Sex Transm Dis 38:892-898. 10.1097/OLQ.0b013e31822c664f. http://dx.doi.org/10.1097/OLQ.0b013e31822c664f.
7. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing. 24th informational supplement; approved standard. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622. http://dx.doi.org/10.1373/clinchem.2008.112797.
9. Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, Allen V, Hoang L, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wylie J, Wong T, Mulvey MR. 2015. Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol 53:191-200. http://dx.doi.org/10.1128/JCM.02589-14.
10. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. 2008. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 35:637-642. http://dx.doi.org/10.1097/OLQ.0b013e31817bdd7e.
11. Balashov S, Mordechai E, Adelson ME, Gygax SE. 2013. Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples. J Mol Di-agn 15:116-129.10.1016/j.jmoldx.2012.08.005. http://dx.doi.org/10.1016/j.jmoldx.2012.08.005.
12. Whiley DM, Tapsall JW, Sloots TP. 2006. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn 8:3-15. http://dx.doi.org/10.2353/jmoldx.2006.050045.